COM:CNSPHARMA
CNS Pharmaceuticals, Inc.
- Stock
Last Close
0.13
22/11 21:00
Market Cap
1.52M
Beta: -
Volume Today
194.47K
Avg: -
Preview
Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page
Dec '17 | Dec '18 | Dec '19 | Dec '20 | Dec '21 | Dec '22 | Dec '23 | ||
|---|---|---|---|---|---|---|---|---|
account payables | 57.50K - | 128.87K 124.12% | 289.50K 124.65% | 946.33K 226.89% | 1.52M 60.92% | 3.68M 141.78% | ||
accumulated other comprehensive income loss | ||||||||
cash and cash equivalents | 110.54K - | 282.74K 155.77% | 7.24M 2,461.15% | 14.04M 93.88% | 5.00M 64.35% | 10.06M 100.93% | 548.72K 94.54% | |
cash and short term investments | 110.54K - | 282.74K 155.77% | 7.24M 2,461.15% | 14.04M 93.88% | 5.00M 64.35% | 10.06M 100.93% | 548.72K 94.54% | |
common stock | 10.27K - | 12.70K 23.60% | 16.45K 29.58% | 23.86K 45.02% | 27.93K 17.06% | 1.62K 94.21% | 6.21K 284.29% | |
deferred revenue | 23.60K - | |||||||
deferred revenue non current | ||||||||
deferrred tax liabilities non current | ||||||||
goodwill | ||||||||
goodwill and intangible assets | ||||||||
intangible assets | ||||||||
inventory | ||||||||
long term debt | ||||||||
long term investments | ||||||||
net debt | 11.28K - | 34.18K 202.98% | -7.24M 21,284.51% | -13.60M 87.81% | -4.62M 66.05% | -9.65M 108.92% | -247.91K 97.43% | |
net receivables | ||||||||
other assets | ||||||||
other current assets | 51.65K - | 33K 36.11% | 652.62K 1,877.64% | 1.46M 123.15% | 2.47M 69.80% | 2.51M 1.47% | 1.04M 58.46% | |
other current liabilities | 41.40K - | 763.25K 1,743.42% | 21.50K 97.18% | 519.80K 2,317.69% | 224.95K 56.72% | 828.39K 268.26% | 5.83M 604.03% | |
other liabilities | -179.32K - | -445.78K 148.59% | -4.09M - | |||||
other non current assets | 95.20K - | 334.14K - | 1.26M 278.23% | 482.81K 61.80% | 104.75K 78.30% | |||
other non current liabilities | 4.09M - | |||||||
othertotal stockholders equity | 150.56K - | 7.05M 4,582.06% | 19.07M 170.57% | 34.87M 82.83% | 41.58M 19.23% | 58.85M 41.54% | 65.13M 10.67% | |
preferred stock | ||||||||
property plant equipment net | 18.16K - | 23.43K 28.99% | 16.11K 31.25% | 5.66K 64.84% | 4.93K 12.91% | |||
retained earnings | -219.36K - | -7.61M 3,369.73% | -11.49M 50.94% | -20.95M 82.32% | -34.98M 67.01% | -50.72M 44.97% | -69.57M 37.17% | |
short term debt | 121.83K - | 316.92K 160.14% | 439.29K - | 387.79K 11.72% | 409.97K 5.72% | 300.81K 26.63% | ||
short term investments | ||||||||
tax assets | ||||||||
tax payables | ||||||||
total assets | 162.19K - | 683.33K 321.31% | 7.91M 1,057.87% | 15.85M 100.37% | 8.76M 44.76% | 13.05M 49.05% | 1.70M 86.97% | |
total current assets | 162.19K - | 588.13K 262.61% | 7.89M 1,242.20% | 15.50M 96.30% | 7.48M 51.75% | 12.56M 68.03% | 1.59M 87.34% | |
total current liabilities | 220.73K - | 1.23M 458.44% | 311.00K 74.77% | 1.91M 512.68% | 2.14M 12.08% | 4.92M 130.40% | 6.13M 24.65% | |
total debt | 121.83K - | 316.92K 160.14% | 439.29K - | 387.79K 11.72% | 409.97K 5.72% | 300.81K 26.63% | ||
total investments | ||||||||
total liabilities | 220.73K - | 1.23M 458.44% | 311.00K 74.77% | 1.91M 512.68% | 2.14M 12.08% | 4.92M 130.40% | 6.13M 24.65% | |
total liabilities and stockholders equity | 162.19K - | 683.33K 321.31% | 7.91M 1,057.87% | 15.85M 100.37% | 8.76M 44.76% | 13.05M 49.05% | 1.70M 86.97% | |
total non current assets | 95.20K - | 18.16K 80.92% | 357.57K 1,868.45% | 1.28M 257.95% | 488.47K 61.84% | 109.68K 77.55% | ||
total non current liabilities | 179.32K - | 445.78K 148.59% | 4.09M - | |||||
total stockholders equity | -58.53K - | -549.30K 838.46% | 7.60M 1,483.78% | 13.95M 83.50% | 6.62M 52.52% | 8.13M 22.82% | -4.43M 154.50% |
All numbers in USD (except ratios and percentages)